Routine C-peptide testing in type 1 diabetes ‘might change diagnosis’
A UK study shows almost 7% of patients tested had another type of diabetes
Routinely testing for C-peptide when patients with type 1 diabetes visit their treating doctor might result in some of them being diagnosed with a different type of diabetes, researchers say.
Endocrinologists from an outpatient clinic in Edinburgh, Scotland, tested non-fasting C-peptide levels when patients diagnosed with type 1 diabetes mellitus (T1DM) for at least three years came for a routine consultation.
